Cholecystokinin (CCK-8) modulates vesicular release of excitatory amine acids in rat hippocampal nerve endings

Neuroscience Letters

Volumn 234, Issue 1, 1997, Pages 67-70

  Breukel, Alexandra I M ^a   Lopes Da Silva, Fernando H ^a   Ghijsen, Wim E J M ^a  

^a Inst Neurbio K   (Netherlands)

Author keywords

Amino acids; Central nervous system; Cholecystokinin; Exocytosis; Synaptosomes

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; EXCITATORY AMINO ACID;

AMINO ACID TRANSPORT; ANIMAL TISSUE; ARTICLE; CELL VACUOLE; EXOCYTOSIS; HIPPOCAMPUS; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTOSOME;

ANIMALS; EXCITATORY AMINO ACIDS; EXOCYTOSIS; GABA AGENTS; HIPPOCAMPUS; MALE; NERVE ENDINGS; NIPECOTIC ACIDS; RATS; RATS, WISTAR; RECEPTORS, CHOLECYSTOKININ; SINCALIDE; SYNAPTIC VESICLES;

EID: 0343118137     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00678-2     Document Type: Article

References (28)

1. Barnes S., Whistler H.L., Hughes J. Effect of cholecystokinin octapeptide on endogenous amino acid release from the rat ventromedial nucleus of the hypothalamus and striatum. J. Neurochem. 56:1991;1409-1416.
2. Boden, P. and Woodruff, G.N., Ionic mechanisms underlying cholecystokinin action in rat brain. In Cholecystokinin, Ann. N. Y. Acad. Sci., Vol. 713, The New York Academy of Science, New York, 1994, pp. 129-137.
3. Böhme G.A., Stutzmann J.M., Blanchard J.C. Excitatory effects of cholecystokinin in rat hippocampus: pharmacological response compatible with 'central'- or B-type CCK receptors. Brain Res. 451:1988;309-318.
4. Böhme, G.A., Bertrand, P., Guyon, C., Capet, M., Pendley, C., Stutzmann, J.M., Doble, A., Dubroeucq, M.G. and Blanchard, J.C., The ureidoacetamides, a novel family of non-peptide CCK-B/gastrin antagonists. In Cholecystokinin, Ann. N. Y. Acad. Sci., Vol. 713, The New York Academy of Science, New York, 1994, pp. 118-120.
5. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:1978;248-252.
6. Breukel, A.I.M., Besselsen, E. and Ghijsen, W.E.J.M., Synaptosomes: a model system to study release of multiple classes of neurotransmitters. In: R.C. Rayne (Ed.) Methods in Molecular Biology, Vol. 72, Humana Press, Totowa, NJ, 1997, pp. 33-47.
7. 28,31)-CCK-25-33S. Eur. J. Neurosci. 4:1992;563-573.
8. Dodd J., Kelly J.S. The actions of cholecystokinin and related peptides on pyramidal neurons of the mammalian hippocampus. Brain Res. 205:1981;337-350.
9. 3H]pBC 264. Eur. J. Pharmacol. 209:1991;185-193.
10. Gaudreau P., Quiron R., St. Pierre S., Pert C.B. Characterization and visualization of CCK receptors in rat brain using [3H]pentagastrin. Peptides. 4:1983;755-762.
11. B receptors mediate CCK-8S-induced activation of dorsal hippocampus CA3 pyramidal neurons: an in vivo electrophysiological study in the rat. Synapse. 21:1995;158-168.
12. Huang S.C., Fortune K.P., Wank S.A., Kopin A.S., Gardner J.D. Multiple affinity states of different cholecystokinin receptors. J. Biol. Chem. 269:1994;26121-26126.
13. Innis R.B., Correa F.M.A., Uhl G.R., Schneider B., Snyder S.H. Cholecystokinin octapeptide-like immunoreactivity: histochemical localization in rat brain. Proc. Natl. Acad. Sci. USA. 76:1979;521-525.
14. Jaffe D.B., Aitken P.G., Nadler J.V. The effects of cholecystokinin and cholecystokinin antagonists on synaptic function in the CA1 region of the rat hippocampal slice. Brain Res. 415:1987;197-203.
15. Léna I., Roques B.P., Durieux C. Dual modulation of dopamine release from anterior nucleus accumbens through cholecystokinin-B receptor subtypes. J. Neurochem. 68:1997;162-168.
16. Lotti V.J., Chang R.S.I. A new and selective nonpeptide antagonist and brain CCK-receptor (CCK-B) ligand: L365,260. Eur. J. Pharmacol. 162:1989;273-280.
17. Migaud M., Roques B.P., Durieux C. Effects of cholecystokinin octapeptide and BC 264, a potent and selective CCK-B agonist on aspartate and glutamate release from rat hippocampal slices. Neuropharmacology. 33:1994;737-743.
18. Migaud M., Roques B.P., Durieux C. Evidence for a high-affinity uptake system for cholecystokinin octapeptide (CCK-8) in rat cortical synaptosomes. Eur. J. Neurosci. 7:1995;1074-1079.
19. + conductance in hippocampal interneurons. J. Neurosci. 17:1997;4994-5003.
20. Naito S., Ueda T. Characterization of glutamate uptake into synaptic vesicles. J. Neurochem. 44:1985;99-109.
21. Nicholls D.G., Attwell D. The release and uptake of excitatory amino acids. Trends Pharmacol. Sci. 11:1990;462-468.
22. Rao R.V., Hadac E.M., Toettger B.F., Miller L.J. Cholecystokinin-induced desensitization, receptor, phosphorylation, and internalization in the CHP212 neuroblastoma cell line. J. Neurochem. 68:1997;2356-2362.
23. Sheehan M.J., de Belleroche J. Facilitation of GABA release by cholecystokinin and caerulein in rat cerebral cortex. Neuropeptides. 3:1983;429-434.
24. Shigeri Y., Shinohara S., Murata S., Fujimoto M., Kawasaki K. Expression of two different cholecystokinin receptors in Xenopus oocytes injected with mRNA from rabbit pancreas and rat hippocampus. Jpn. J. Pharmacol. 72:1996;9-15.
25. Somogyi P., Hodgson A.J., Smith A.D. Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin-immunoreactive material. J. Neurosci. 4:1984;2590-2603.
26. 2+ dependent regulation of presynaptic stimulus-secretion coupling. J. Neurochem. 53:1989;1188-1194.
27. Verhage M., Ghijsen W.E.J.M., Nicholls D.G., Wiegant V.M. Characterization of the release of cholecystokinin from isolated nerve terminals. J. Neurochem. 56:1991;1394-1400.
28. Williams J.A. Cholecystokinin, a hormone and a neurotransmitter. Biomed. Res. 3:1982;107-121.